Skip to main content
Clinical Trials/CTRI/2023/07/054656
CTRI/2023/07/054656
Not yet recruiting
Phase 4

Comparative evaluation of clinical andradiographic effects of ascorbic acidaugmented platelet rich fibrin versus plateletrich fibrin alone in the treatment of Grade IIfurcation involvement: A randomisedcontrolled study. - NI

DR TUSHARIKA SHARMA0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: K053- Chronic periodontitis
Sponsor
DR TUSHARIKA SHARMA
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
DR TUSHARIKA SHARMA

Eligibility Criteria

Inclusion Criteria

  • Age group between twenty five years to sixty years
  • Willing to participate in study.
  • Availability for follow\-up appointments
  • Patients with mandibular molars and grade II furcation.
  • Clinical attachment loss more than or equal to 5 mm
  • Probing depth more than or equal to 6 mm
  • Radiographic intraosseous defect more than or equal to 3 mm
  • Systemically healthy

Exclusion Criteria

  • Pregnant or lactating mothers.
  • Patients with known systemic disease or blood dyscrasias or on any
  • medication known to interfere with outcomes of periodontal therapy.
  • Current smokers, tobacco chewers and alcoholic patients.
  • Previously treated for periodontal disease within 6 months.

Outcomes

Primary Outcomes

Not specified

Similar Trials